Connect your AI

Insight Molecular Diagnostics Inc. IMDX Q4 2024 Annual earnings

Reported March 24, 2025 · After market close

Revenue$1.5MBeat by $1.3M Diluted EPS$0.48Beat by $0.91

Revenue estimate$158.6K

EPS estimate-$0.43

Next report

Aug 10, 2026 (In 4 weeks)

Revenue estimate$437.5K

EPS estimate-$0.24

Financials

Q4 2024

Income statement

Revenue$1.5M+373%

Gross profit$617.0K—

Operating income-$33.6M-108%

Net income-$33.5M-110%

EPS (diluted)-$2.30-11.1%

Balance sheet

Cash & equivalents$8.6M-8.4%

Total debt$3.6M—

Total equity-$12.3M-160%

Total assets$35.1M-53.2%

Cash flow

Operating cash flow-$5.4M-21.0%

CapEx$214.0K-18.9%

Free cash flow-$5.6M-18.7%

Valuation & ratios

Profitability

Gross margin44%—

Operating margin-3,245.1%+51,221pp

Net margin-3,225%+9,412pp

FCF margin-1,127.3%—

Returns & leverage

Current ratio1.6×+0.1×

Versus estimates

Revenue

Q1 2026$32.0KMiss by $197.2K Q4 2025$1.1MBeat by $854.0K Q3 2025$260.0KMiss by $25.0K Q2 2025$518.0KBeat by $218.0K Q1 2025$2.1MBeat by $2.0M

Q4 2024$1.5MBeat by $1.3M

Diluted EPS

Q1 2026-$0.28Miss by $0.02 Q4 2025-$0.27Miss by $0.03 Q3 2025-$0.34Miss by $0.10 Q2 2025-$0.30Miss by $0.07 Q1 2025-$0.26Miss by $0.02

Q4 2024$0.48Beat by $0.91

Ask the moment Insight Molecular Diagnostics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Insight Molecular Diagnostics Inc. report Q4 2024 earnings?: Insight Molecular Diagnostics Inc. (IMDX) reported Q4 2024 earnings on March 24, 2025 after market close.
What were Insight Molecular Diagnostics Inc.'s Q4 2024 revenue and EPS?: Insight Molecular Diagnostics Inc. reported revenue of $1.5M and diluted EPS of $0.48 for Q4 2024.
Did Insight Molecular Diagnostics Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $158.6K by $1.3M. EPS beat the consensus estimate of $-0.43 by $0.91.
Where can I find Insight Molecular Diagnostics Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-043852) directly on SEC EDGAR. The filing index links above go to sec.gov.